←
Hesham H Malik389 posts
Hesham H Malik avatar

Hesham H Malik

@NoLimitIR
◷ Joined July 2016▧ 12 Photos and videos
Sandeep Bagla MD avatar
⟳ Hesham H Malik retweeted
Sandeep Bagla MD@SandeepBaglaMD·13 Jan 2025

Join us for a Happy Hour hosted by IR Centers during the Annual @SIRspecialists Meeting! 🗓 When: March 31st at 6:00 PM 📍 Where: Harriet’s Rooftop, #Nashville Mingle with fellow physicians, residents, and fellows, and connect with the #IRCenters team. Learn how we’re shaping the future of healthcare through innovation and collaboration. This is your chance to relax, network, and discover our mission to revolutionize interventional radiology and beyond! 👉 RSVP is mandatory for tickets. Secure your spot now: forms.gle/8ZTtHeP9s9BC5Me86 Space is limited, so RSVP today! You will get a confirmation email when the guest list is finalized as well. We can’t wait to see you there! @SIRRFS @IR_SchwartzMD @AbinSajanMD @AriIsaacsonMD @AlexPavidapha @marcus8j @NoLimitIR @SuiteLifeofIR @DonGarbettMD @SIR_ECS @bonesz @RajNarayanan67 @pryce227 @riadsalemIR @SamMouli @brianswongmd @UsaProstate @IRcenters

Sandeep Bagla MD avatar
⟳ Hesham H Malik retweeted
Sandeep Bagla MD@SandeepBaglaMD·8 Jan 2025

Changing the future of #Irad ⁦@SIRRFS⁩ ⁦@SIRspecialists⁩ ⁦@AriIsaacsonMD⁩ ⁦@AlexPavidapha⁩ ⁦@NoLimitIR⁩ ⁦@UsaProstate⁩ ⁦@IRcenters⁩ linkedin.com/posts/sandeep-b…

Sandeep Bagla MD avatar
⟳ Hesham H Malik retweeted
Sandeep Bagla MD@SandeepBaglaMD·19 Dec 2024

The Unreasonable Appeal Process by Blue Cross Blue Shield of Alabama (BCBSAL) 🧵 1/ Physicians advocate tirelessly for their patients. But BCBSAL denies medically necessary procedures & charges physicians to appeal these denials. Yes, you read that right—physicians must pay to fight for patient care. Here’s why this needs to change: 👇 2/ If BCBSAL denies a procedure (e.g., deemed “not medically necessary”), physicians must complete the internal appeal process. If denied again, they must escalate to IMEDICS (external review). 3/ Here’s the kicker: Physicians pay $50 for disputes <$1,000 or $250 for disputes >$1,000—just to appeal! This shifts costs to physicians, not the insurance company managing benefits. Completely unacceptable. 😡 4/ This policy discourages appeals, even for procedures based on sound medical evidence from experts in Urology & Interventional Radiology. It prioritizes insurer profits over patient access to care. 5/ Want to take action? Here’s how: Contact the Alabama Department of Insurance to complain: 📧 Email: ConsumerServices@insurance.alabama.gov 📞 Phone: (334) 241-4141 📝 Online Form: Complaint Form 6/ Demand change from BCBSAL: 📞 Customer Service: 1-800-292-8868 📬 Address: 450 Riverchase Parkway E, Birmingham, AL 35244 7/ Physicians shouldn’t pay to advocate for their patients. Let’s stand together to hold BCBSAL accountable. Patients & their physicians deserve better. RT to spread awareness. 📢 #Advocacy #MedicalNecessity #HealthcarePolicy #BCBSAL #InsuranceReform @BlueCrossPA @BCBSAssociation @BCBSAlabama @CMSGov @aldemocrats @AlabamaFTBL @Bama_247

Post attachment
iRadPulse avatar
⟳ Hesham H Malik retweeted
iRadPulse@iRadPulse·23 Mar 2024

🌟 Presenting Abstract 3/4 of the Year from @SIRspecialists 2024 Conference, as featured in @JVIRmedia! #SIR24SLC #SIR2024 Abstract 3 of 4 : Explore "Long-Term Efficacy of Hemorrhoid Artery Embolization" - an important study in hemorrhoid treatment. 🎉🔬🩺 🎯 Study Goal: Assessing the effectiveness of hemorrhoid artery embolization (HAE) in treating symptomatic hemorrhoids long-term, in 221 patients resistant to other treatments. A step forward in non-surgical hemorrhoid therapy! 🏥💡 🔍 Study Details: ❍ Patients: 221 (115 males, 106 females) ❍ Age Average: 57.1 years ❍ Hemorrhoid Grade Average: 2.1 ❍ Follow-Up: 1-, 3-, 6-12 months post-embolization 📊 Results: ❍ 100% technical success (221/221) ❍ 90% clinical success at 1 month; 21 needed re-embolization ❍ Significant improvements in all measured outcomes (HSS, HRP, QoL, FBS, HG) at follow-ups ❍ Minor adverse events: 4, all resolved within 30 days 🔍 Insightful Observation: 18 of 21 treatment failures were linked to a dominant middle rectal artery supply. 📌 Conclusion: HAE emerges as a promising outpatient treatment for persistent symptomatic internal hemorrhoids, demonstrating notable long-term efficacy and safety. Kudos to @AbinSajanMD, @AlexPavidapha, @SandeepBaglaMD and the team for this impactful research! 🙏 @ColumbiaVIR, @IRcenters, @columbiaimaging, @columbiaradres How could this change your approach to hemorrhoid treatment? Stay tuned for the 4th and final abstract summary in our celebrated series! 🚀🔍 📣 Don’t miss out on the latest research insights. Subscribe to our newsletter: iradpulse.beehiiv.com/subscr… #Hemorrhoids #NonSurgicalTreatment #PatientCare #MedicalResearch #Healthcare #Radiology 🎗️🔍👩‍⚕️🚑

Post attachment